Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

International Journal of Radiation Oncology Biology Physics

Volumn 37, Issue 3, 1997, Pages 543-550

  Hanks, Gerald E ^a   Schultheiss, Timothy E ^a   Hanlon, Alexandra L ^a   Hunt, Margie ^a   Lee, W Robert ^a   Epstein, Barry E ^a,b   Coia, Lawrence R ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY HOSPITAL   (United States)

Author keywords

Dose escalation; Late morbidity; Prostate cancer; Treatment optimization

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; DOSE RESPONSE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION SICKNESS; STATISTICAL ANALYSIS; UROGENITAL TRACT DISEASE;

DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREGNANCY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; REGRESSION ANALYSIS; TREATMENT FAILURE;

EID: 0030936848     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(96)00602-5     Document Type: Article

References (34)

1. Boring, C. C.; Squires, T. S.; Tong, T.; Montgomery, S. Cancer statistics, 1994. CA Cancer J. Clin. 44:7-26; 1994.
2. Chodak, G. W.; Thisted, R. A.; Gerber, G. S.; Johansson, J. E.; Adolfsson, J.; Jones, G. W.; Chisholm, G. D.; Moskovitz, B.; Livne, P. M.; Warner, J. Results of conservative management of clinically localized prostate cancer. N. Engl. J. Med. 330:242-248; 1994.
3. Coia, L.; Myerson, R. J.; Tepper, J. E. Late effects of radiation therapy on the gastrointestinal tract. Int. J. Radiat. Oncol. Biol. Phys. 31:1213-1236; 1995.
4. Corn, B. W.; Hanks, G. E.; Schultheiss, T. E.; Hunt, M. A.; Lee, W. R.; Coia, L. R. Conformal treatment of prostate cancer with improved targeting: Superior prostate-specific antigen response compared to standard treatment. Int. J. Radiat. Oncol. Biol. Phys. 32:325-330; 1995.
5. Hanks, G. E. Optimizing the radiation treatment and outcome of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 11:1235-1245; 1985.
6. Hanks, G. E.; Hanlon, A. L.; Hudes, G.; Lee, W. R.; Suasin, W.; Schultheiss, T. E. Patterns of failure analysis of patients with high pretreatment PSA treated by radiation therapy: The need for improved systemic and loco-regional treatment. J. Clin. Oncol. 14:1093-1097; 1996.
7. Hanks, G. E.; Lee, W. R.; Schultheiss, T. E. Clinical and biochemical evidence of control of prostate cancer at five years after external beam radiation. J. Urol. 154:456-459; 1995.
8. Hanks, G. E.; Leibel, S.; Krall, J. M.; Kramer, S. Dose response observations for local control of adenocarcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 11:153-157; 1985.
9. Hanks, G. E.; Schultheiss, T. E.; Hunt, M. Clinical experience with 3D radiotherapy treating prostate cancer. Proceedings of International Symposium on 3D Radiation Treatment of Prostate Cancer; 1993.
10. Hanks, G. E.; Schultheiss, T. E.; Hunt, M. A.; Epstein, B. Factors influencing incidence of acute Grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 31:25-29; 1995.
11. ICRU Report No. 50. International Commission on Radiation Units and Measurements: Prescribing, Recording, and Reporting Photon Beam Therapy. Washington, D.C.; International Commission on Radiation Units and Measurements; 1993.
12. Kalbfleisch, J. D.; Ross, L. P. The statistical analysis of failure time data. New York: John Wiley & Sons; 1980.
13. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:447-457; 1958.
14. Lawless, J. E. Statistical models and methods for lifetime data. New York: John Wiley & Sons; 1982.
15. Lee, W. R.; Hanks, G. E.; Hanlon, A.; Schultheiss, T. E.; Hunt, M. A. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect. Int. J. Radiat. Oncol. Biol. Phys. 35:251-257; 1996.
16. Lee, W. R.; Hanks, G. E.; Schultheiss, T. E.; Corn, B. W.; Hunt, M. A. Localized prostate cancer treated by external beam radiotherapy alone: Serum PSA driven outcome analysis. J. Clin. Oncol. 13:464-469; 1995.
17. Leibel, S. A. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: Interim report of a phase 1 dose-escalation study. Int. J. Radiat. Oncol. Biol. Phys. 152:1792-1798; 1994.
18. Lichter, A. S. Three-dimensional conformal radiation therapy: A testable hypothesis. Int. J. Radiat. Oncol. Biol. Phys. 21:853-855; 1991.
19. Murphy, G. P.; Mettlin, C.; Menck, H.; Winchester, D. P.; Davidson, A. M. National patterns of prostate cancer treatment by radical prostatectomy: Results of a survey by the American College of Surgeons Commission on Cancer. J. Urol. 152:1817-1819; 1994.
20. Partin, A. W.; Pound, C. R.; Clemens, Q.; Epstein, J. I.; Walsh, P. C. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol. Clin. North Am. 29:1-13; 1993.
21. Perez, C. A.; Hanks, G. E.; Leibel, S. A.; Zietman, A. L.; Fuks, Z.; Lee, W. R. Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Int. J. Radiat. Oncol. Biol. Phys. 72:3156-3173; 1993.
22. Pinover, W. H.; Hanlon, A.; Lee, W. R.; Kaplan, E. J.; Hanks, G. E. Prostate cancer patients upstaged by imaging and treated with irradiation: an outcome based analysis. Cancer 77:1334-1341; 1996.
23. Sandler, H.; McLaughlin, P. W.; Ten Haken, R.; Addison, H.; Forman, J.; Lichter, A. 3D conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients. Int. J. Radiat. Oncol. Biol. Phys. 27:135; 1993.
24. Sandler, H. M.; McLaughlin, P. W.; Kish, K. E.; Lichter, A. S. Results of 3D conformal radiotherapy in the treatment of 707 patients with localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:141; 1995.
25. Sandler, H. M.; Perez-Tamayo, C.; Ten Haken, R. K.; Lichter, A. S. Dose escalation for stage C (T3) prostate cancer: Minimal rectal toxicity observed using conformal therapy. Radiother. Oncol. 23:53-54; 1992.
26. SAS Institute, I.. SAS/STAT users guide, version 6 fourth edition, vol. 2. Cary, NC: SAS Institute, Inc.
27. SAS Institute Inc. SAS technical report P-179, additional SAS/STAT procedures, release 6.03. Cary, NC: NCL SAS Institute Inc.; 1988:49-89.
28. Schultiess, T. E.; Hanks, G. E.; Hunt, M. A.; Lee, W. R. Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 32:643-650; 1995.
29. Schultiess, T. E.; Lee, W. R.; Hunt, M. A.; Hanlon, A. L.; Peter, R. S.; Hanks, G. E. Factors related to GI and GU complications in conformal and conventional radiation treatment of cancer of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 32:251; 1995.
30. Schultiess, T. E.; Lee, W. R.; Hunt, M. A.; Hanlon, A. L.; Peter, R. S.; Hanks, G. E. Factors related to late GI and GU complications in conformal and conventional radiation treatment of cancer of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 32:251; 1995.
31. Soffen, T. M.; Hanks, G. E.; Hunt, M. A.; Epstein, B. E. Conformal static field radiation therapy treatment of early prostate cancer versus non-conformal techniques: A reduction in acute morbidity. Int. J. Radiat. Oncol. Biol. Phys. 24:485-488; 1992.
32. Zagars, G. K.; Pollack, A. Radiation therapy for T1 and T2 prostate cancer: Prostate-specific antigen and disease outcome. Urol. 45:476-483; 1995.
33. Zelefsky, M.; Leibel, S.; Burman, C.; Kutcher, G.; Mohan, R.; Kelson, S.; Fuks, Z. Early observations of acute and chronic toxicity and PSA response in patients with carcinoma of the prostate treated on a dose escalation study with 3D-CRT. Int. J. Radiat. Oncol. Biol. Phys. 30:156; 1994.
34. Zelefsky, M. J.; Leibel, S. A.; Kutcher, G. J.; Kelson, S.; Ling, C.; Fuks, Z. The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. CAJ. Sci. Am. 1:142-150; 1995.